CARLYLE GROUP INC/THE (CG) Fundamental Analysis & Valuation

NASDAQ:CG • US14316J1088

Current stock price

47.81 USD
+0.09 (+0.19%)
At close:
47.81 USD
0 (0%)
After Hours:

This CG fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

4

1. CG Profitability Analysis

1.1 Basic Checks

  • CG had positive earnings in the past year.
  • In the past year CG has reported a negative cash flow from operations.
  • Of the past 5 years CG 4 years were profitable.
  • The reported operating cash flow has been mixed in the past 5 years: CG reported negative operating cash flow in multiple years.
CG Yearly Net Income VS EBIT VS OCF VS FCFCG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B -2B 4B

1.2 Ratios

  • CG's Return On Assets of 2.78% is in line compared to the rest of the industry. CG outperforms 51.46% of its industry peers.
  • With a decent Return On Equity value of 14.04%, CG is doing good in the industry, outperforming 71.13% of the companies in the same industry.
  • CG's Return On Invested Capital of 4.13% is in line compared to the rest of the industry. CG outperforms 56.49% of its industry peers.
Industry RankSector Rank
ROA 2.78%
ROE 14.04%
ROIC 4.13%
ROA(3y)1.44%
ROA(5y)4.81%
ROE(3y)6.84%
ROE(5y)19.31%
ROIC(3y)N/A
ROIC(5y)N/A
CG Yearly ROA, ROE, ROICCG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40

1.3 Margins

  • CG has a Profit Margin (16.92%) which is comparable to the rest of the industry.
  • In the last couple of years the Profit Margin of CG has grown nicely.
  • The Operating Margin of CG (23.24%) is comparable to the rest of the industry.
  • In the last couple of years the Operating Margin of CG has grown nicely.
  • CG has a better Gross Margin (64.76%) than 71.13% of its industry peers.
  • In the last couple of years the Gross Margin of CG has remained more or less at the same level.
Industry RankSector Rank
OM 23.24%
PM (TTM) 16.92%
GM 64.76%
OM growth 3Y-14.75%
OM growth 5Y2.14%
PM growth 3Y-15.05%
PM growth 5Y7.35%
GM growth 3Y-5.41%
GM growth 5Y0.03%
CG Yearly Profit, Operating, Gross MarginsCG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 60 80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

0

2. CG Health Analysis

2.1 Basic Checks

  • Compared to 1 year ago, CG has about the same amount of shares outstanding.
  • CG has more shares outstanding than it did 5 years ago.
  • The debt/assets ratio for CG is higher compared to a year ago.
CG Yearly Shares OutstandingCG Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M
CG Yearly Total Debt VS Total AssetsCG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B 20B 25B

2.2 Solvency

  • CG has an Altman-Z score of 0.67. This is a bad value and indicates that CG is not financially healthy and even has some risk of bankruptcy.
  • CG has a Altman-Z score of 0.67. This is comparable to the rest of the industry: CG outperforms 47.70% of its industry peers.
  • A Debt/Equity ratio of 2.25 is on the high side and indicates that CG has dependencies on debt financing.
  • CG has a worse Debt to Equity ratio (2.25) than 79.92% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.25
Debt/FCF N/A
Altman-Z 0.67
ROIC/WACCN/A
WACCN/A
CG Yearly LT Debt VS Equity VS FCFCG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5B 10B

2.3 Liquidity

  • CG has a Current Ratio of 0.56. This is a bad value and indicates that CG is not financially healthy enough and could expect problems in meeting its short term obligations.
  • The Current ratio of CG (0.56) is worse than 73.64% of its industry peers.
  • CG has a Quick Ratio of 0.56. This is a bad value and indicates that CG is not financially healthy enough and could expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 0.56, CG is doing worse than 73.64% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.56
Quick Ratio 0.56
CG Yearly Current Assets VS Current LiabilitesCG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. CG Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an nice 9.84% over the past year.
  • CG shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 14.42% yearly.
  • Looking at the last year, CG shows a very negative growth in Revenue. The Revenue has decreased by -11.91% in the last year.
  • Measured over the past years, CG shows a quite strong growth in Revenue. The Revenue has been growing by 10.25% on average per year.
EPS 1Y (TTM)9.84%
EPS 3Y-2.52%
EPS 5Y14.42%
EPS Q2Q%9.78%
Revenue 1Y (TTM)-11.91%
Revenue growth 3Y2.5%
Revenue growth 5Y10.25%
Sales Q2Q%15.11%

3.2 Future

  • CG is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 11.45% yearly.
  • CG is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 14.83% yearly.
EPS Next Y16.86%
EPS Next 2Y18.13%
EPS Next 3Y14.77%
EPS Next 5Y11.45%
Revenue Next Year18.66%
Revenue Next 2Y17.41%
Revenue Next 3Y14.83%
Revenue Next 5YN/A

3.3 Evolution

  • The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CG Yearly Revenue VS EstimatesCG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2B 4B 6B 8B
CG Yearly EPS VS EstimatesCG Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2 4 6 8

More info and screens

Find the best growth stocksShow best growing peers

5

4. CG Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 11.89 indicates a reasonable valuation of CG.
  • The rest of the industry has a similar Price/Earnings ratio as CG.
  • Compared to an average S&P500 Price/Earnings ratio of 26.54, CG is valued rather cheaply.
  • The Price/Forward Earnings ratio is 10.18, which indicates a very decent valuation of CG.
  • Based on the Price/Forward Earnings ratio, CG is valued a bit cheaper than 68.20% of the companies in the same industry.
  • CG's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 21.68.
Industry RankSector Rank
PE 11.89
Fwd PE 10.18
CG Price Earnings VS Forward Price EarningsCG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, CG is valued a bit cheaper than the industry average as 64.44% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 21.1
CG Per share dataCG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10 15

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • CG's earnings are expected to grow with 14.77% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.71
PEG (5Y)0.82
EPS Next 2Y18.13%
EPS Next 3Y14.77%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

5

5. CG Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 2.86%, CG has a reasonable but not impressive dividend return.
  • Compared to an average industry Dividend Yield of 6.53, CG has a dividend in line with its industry peers.
  • Compared to an average S&P500 Dividend Yield of 1.82, CG pays a better dividend.
Industry RankSector Rank
Dividend Yield 2.86%

5.2 History

  • The dividend of CG decreases each year by -1.03%.
  • CG has paid a dividend for at least 10 years, which is a reliable track record.
  • CG has not decreased its dividend in the past 5 years, so it has a somewhat stable track record.
Dividend Growth(5Y)-1.03%
Div Incr Years0
Div Non Decr Years5
CG Yearly Dividends per shareCG Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5

5.3 Sustainability

  • 62.46% of the earnings are spent on dividend by CG. This is not a sustainable payout ratio.
DP62.46%
EPS Next 2Y18.13%
EPS Next 3Y14.77%
CG Yearly Income VS Free CF VS DividendCG Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B -2B
CG Dividend Payout.CG Dividend Payout, showing the Payout Ratio.CG Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

CG Fundamentals: All Metrics, Ratios and Statistics

CARLYLE GROUP INC/THE

NASDAQ:CG (4/29/2026, 8:02:03 PM)

After market: 47.81 0 (0%)

47.81

+0.09 (+0.19%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Industry Strength29.19
Industry Growth54.66
Earnings (Last)02-06
Earnings (Next)05-07
Inst Owners65.31%
Inst Owner Change-0.26%
Ins Owners25.99%
Ins Owner Change-0.99%
Market Cap17.27B
Revenue(TTM)4.78B
Net Income(TTM)808.70M
Analysts76.8
Price Target65.63 (37.27%)
Short Float %5.46%
Short Ratio4.44
Dividend
Industry RankSector Rank
Dividend Yield 2.86%
Yearly Dividend1.41
Dividend Growth(5Y)-1.03%
DP62.46%
Div Incr Years0
Div Non Decr Years5
Ex-Date02-13
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-4.84%
Min EPS beat(2)-7.63%
Max EPS beat(2)-2.05%
EPS beat(4)1
Avg EPS beat(4)1.67%
Min EPS beat(4)-7.63%
Max EPS beat(4)16.95%
EPS beat(8)3
Avg EPS beat(8)-0.43%
EPS beat(12)6
Avg EPS beat(12)3.19%
EPS beat(16)9
Avg EPS beat(16)2.88%
Revenue beat(2)1
Avg Revenue beat(2)-11.97%
Min Revenue beat(2)-24.76%
Max Revenue beat(2)0.81%
Revenue beat(4)3
Avg Revenue beat(4)-3.78%
Min Revenue beat(4)-24.76%
Max Revenue beat(4)5.83%
Revenue beat(8)3
Avg Revenue beat(8)-4.61%
Revenue beat(12)5
Avg Revenue beat(12)-2.68%
Revenue beat(16)6
Avg Revenue beat(16)-2.04%
PT rev (1m)-3.36%
PT rev (3m)-4.42%
EPS NQ rev (1m)-9.65%
EPS NQ rev (3m)-11.99%
EPS NY rev (1m)-0.96%
EPS NY rev (3m)-3.92%
Revenue NQ rev (1m)-1.46%
Revenue NQ rev (3m)-1.64%
Revenue NY rev (1m)-1.24%
Revenue NY rev (3m)-2.59%
Valuation
Industry RankSector Rank
PE 11.89
Fwd PE 10.18
P/S 3.61
P/FCF N/A
P/OCF N/A
P/B 3
P/tB 3.29
EV/EBITDA 21.1
EPS(TTM)4.02
EY8.41%
EPS(NY)4.7
Fwd EY9.83%
FCF(TTM)-9.34
FCFYN/A
OCF(TTM)-9.07
OCFYN/A
SpS13.23
BVpS15.95
TBVpS14.55
PEG (NY)0.71
PEG (5Y)0.82
Graham Number37.9854 (-20.55%)
Profitability
Industry RankSector Rank
ROA 2.78%
ROE 14.04%
ROCE 5.16%
ROIC 4.13%
ROICexc 4.85%
ROICexgc 8.72%
OM 23.24%
PM (TTM) 16.92%
GM 64.76%
FCFM N/A
ROA(3y)1.44%
ROA(5y)4.81%
ROE(3y)6.84%
ROE(5y)19.31%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y-26%
ROICexgc growth 5Y-2.63%
ROICexc growth 3Y-19.72%
ROICexc growth 5Y-0.34%
OM growth 3Y-14.75%
OM growth 5Y2.14%
PM growth 3Y-15.05%
PM growth 5Y7.35%
GM growth 3Y-5.41%
GM growth 5Y0.03%
F-Score4
Asset Turnover0.16
Health
Industry RankSector Rank
Debt/Equity 2.25
Debt/FCF N/A
Debt/EBITDA 9.94
Cap/Depr 51.74%
Cap/Sales 2.08%
Interest Coverage 12.11
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.56
Quick Ratio 0.56
Altman-Z 0.67
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)43.61%
Cap/Depr(5y)131.51%
Cap/Sales(3y)1.92%
Cap/Sales(5y)4.22%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)9.84%
EPS 3Y-2.52%
EPS 5Y14.42%
EPS Q2Q%9.78%
EPS Next Y16.86%
EPS Next 2Y18.13%
EPS Next 3Y14.77%
EPS Next 5Y11.45%
Revenue 1Y (TTM)-11.91%
Revenue growth 3Y2.5%
Revenue growth 5Y10.25%
Sales Q2Q%15.11%
Revenue Next Year18.66%
Revenue Next 2Y17.41%
Revenue Next 3Y14.83%
Revenue Next 5YN/A
EBIT growth 1Y-16.93%
EBIT growth 3Y-12.62%
EBIT growth 5Y12.61%
EBIT Next Year-2.4%
EBIT Next 3Y10.78%
EBIT Next 5Y2%
FCF growth 1Y-303.12%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-331.27%
OCF growth 3YN/A
OCF growth 5YN/A

CARLYLE GROUP INC/THE / CG Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for CARLYLE GROUP INC/THE?

ChartMill assigns a fundamental rating of 4 / 10 to CG.


What is the valuation status for CG stock?

ChartMill assigns a valuation rating of 5 / 10 to CARLYLE GROUP INC/THE (CG). This can be considered as Fairly Valued.


What is the profitability of CG stock?

CARLYLE GROUP INC/THE (CG) has a profitability rating of 4 / 10.


How financially healthy is CARLYLE GROUP INC/THE?

The financial health rating of CARLYLE GROUP INC/THE (CG) is 0 / 10.


How sustainable is the dividend of CARLYLE GROUP INC/THE (CG) stock?

The dividend rating of CARLYLE GROUP INC/THE (CG) is 5 / 10 and the dividend payout ratio is 62.46%.